26 Results for "

rat MAO-A

" in MedChemExpress (MCE) Product Catalog:
Products (26)

26 Results for "rat MAO-A" in MCE Product Catalog:

8
8 Publications Verification
Cat. No.: HY-14280
CAS No.: 130929-57-6
Purity:  99.97%
Target:  

COMT

Research Areas:  

Neurological Disease Cancer

Entacapone is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 μM). Entacapone can be used for the research of Parkinson's disease . Entacapone serves as a inhibitor of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1311
CAS No.: 62-68-0
Synonyms: SKF-525A; U-5446; RP-5171
Proadifen (SKF-525A) hydrochloride is a non-competitive Cytochrome P450 inhibitor with an IC50 value of 19 μM. Proadifen hydrochloride reduces monoamine oxidase A (MAO-A) activity and reverses the antidepressantlike behavioral effect of Imipramine (HY-B1490A) and Desipramine (HY-B1272A) in rats. Proadifen hydrochloride also reduces N, N-dimethyltryptamine (DMT) metabolism in liver microsomes and inhibits N-demethylationand Acridone (HY-W007771) formation. Proadifen hydrochloride augments Lipopolysaccharide (LPS) (HY-D1056)-induced fever and exacerbates Prostaglandin E2 (PGE2) (HY-101952) levels in the rat. Proadifen hydrochloride is promising for research of metabolism-related deseases, ovarian carcinoma, inflammation and dopamine neurons-related deseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100588
CAS No.: 61350-00-3
Purity:  99.94%
Target:  

mGluR

Research Areas:  

Neurological Disease

VU0364770 is a selective and potent positive allosteric modulator (PAM) of mGlu4. VU0346770 exhibits EC50s of 290 nM and 1.1 μM at rat mGlu4 and human mGlu4 receptor, respectively. VU0364770 exhibits antagonist activity at mGlu5 with a potency of 17.9 μM and PAM activity at mGlu6 with a potency of 6.8 μM. VU0364770 also possesses activity at MAO with Ki values of 8.5 and 0.72 μM for human MAO-A and human MAO-B, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100588A
CAS No.: 1414842-70-8
Purity:  99.70%
Target:  

mGluR

Research Areas:  

Neurological Disease

VU0364770 hydrochloride is a selective and potent positive allosteric modulator (PAM) of mGlu4. VU0346770 hydrochloride exhibits EC50s of 290 nM and 1.1 μM at rat mGlu4 and human mGlu4 receptor, respectively. VU0364770 hydrochloride exhibits antagonist activity at mGlu5 with a potency of 17.9 μM and PAM activity at mGlu6 with a potency of 6.8 μM. VU0364770 hydrochloride also possesses activity at MAO with Ki values of 8.5 and 0.72 μM for human MAO-A and human MAO-B, respectively .
loading...
    loading...
Cat. No.: HY-14895
CAS No.: 173352-21-1
Purity:  99.96%
Synonyms: CM346
Fabomotizole (CM346) is an insecticide with anxiolytic, antianxiety, and neuroprotective activities and a substrate of p-glycoprotein. Fabomotizole inhibits the ST-segment depression induced by isoproterenol in a rat model of acute subendocardial ischemia. Fabomotizole also inhibits Giardia lamblia and has the potential to inhibit giardiasis. Fabomotizole also targets Sigma1R, NRH:quinone reductase 2 (NQO2), and MAO-A to exert anxiolytic effects .
loading...
    loading...
Cat. No.: HY-14203
CAS No.: 174756-44-6
Purity:  99.89%
Synonyms: FCE 28073; (R)-EMD 1195686
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

(R)-Safinamide (FCE 28073) is the enantiomer of Safinamide (HY-70057). (R)-Safinamide is an orally active, alanine-derived monoamine oxidase inhibitor with an IC50 of 1.77 μM for rat MAO-B and an IC50 of 50 μM for rat MAO-A. (R)-Safinamide regulates the activity of monoamine oxidase isoforms in brain homogenates. (R)-Safinamide is used in epilepsy research .
loading...
    loading...
Cat. No.: HY-14280S
CAS No.: 1185241-19-3
Purity:  ≥98.0%
Entacapone-d10 is the deuterium labeled Entacapone. Entacapone is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 μM). Entacapone can be used for the research of Parkinson's disease . Entacapone serves as a inhibitor of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders .
loading...
    loading...
Cat. No.: HY-N12485
CAS No.: 119229-96-8
Research Areas:  

Neurological Disease

MAO-A inhibitor 1 is a stilbene-based chemically modified derivative of Resveratrol (HY-16561). MAO-A inhibitor 1 is a competitive and selective MAO-A inhibitor. MAO-A inhibitor 1 can be used for research on MAO-A-related diseases, such as depression .
loading...
    loading...
Cat. No.: HY-100027A
CAS No.: 127917-66-2
Purity:  99.96%
Research Areas:  

Neurological Disease

Ro 41-1049 hydrochloride is a highly selective, reversible MAO-A inhibitor. Ro 41-1049 hydrochloride effectively blocks the Quinpirole (HY-B1752)-induced increase in dopamine D2-like receptor density in the nucleus accumbens and alters the pattern of behavioral sensitization, shifting animals' responses from enhanced motor activity to immobile self-directed gaping behavior. Tritium-labeled Ro 41-1049 hydrochloride serves as a high-affinity radioligand, enabling accurate mapping of the distribution and abundance of MAO-A in the central nervous system, peripheral organs, and human brain via quantitative enzyme autoradiography. Ro 41-1049 hydrochloride can be used for basic research on depression and other related diseases .
loading...
    loading...
Cat. No.: HY-14280R
CAS No.: 130929-57-6
Research Areas:  

Neurological Disease Cancer

Entacapone (Standard) is the analytical standard of Entacapone. This product is intended for research and analytical applications. Entacapone is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 µM). Entacapone can be used for the research of Parkinson's disease . Entacapone serves as a inhibitor of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders .
loading...
    loading...
Cat. No.: HY-RS08021
Research Areas:  

Others

Maoa Rat Pre-designed siRNA Set A contains three designed siRNAs for Maoa gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-14280A
CAS No.: 1047659-02-8
Target:  

COMT

Research Areas:  

Neurological Disease Cancer

Entacapone sodium salt is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone sodium salt inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone sodium salt is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 µM). Entacapone sodium salt can be used for the research of Parkinson's disease . Entacapone sodium salt serves as as a inhibit of FTO demethylation with an IC50 of 3.5 μM, can be used for the research of metabolic disorders .
loading...
    loading...
Cat. No.: HY-123665
CAS No.: 1494477-03-0
Purity:  99.22%
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

PSB-1410 is a monoamine oxidase B (MAO-B) inhibitor, with an IC50 of 0.227 nM against human MAO-B and an IC50 of 1.01 nM against rat MAO-B. PSB-1410 can be used for the research of Parkinson's disease .
loading...
    loading...
Cat. No.: HY-B1311R
CAS No.: 62-68-0
Synonyms: SKF-525A (Standard); U-5446 (Standard); RP-5171 (Standard)
Proadifen (hydrochloride) (Standard) is the analytical standard of Proadifen (hydrochloride). This product is intended for research and analytical applications. Proadifen (SKF-525A) hydrochloride is a non-competitive Cytochrome P450 inhibitor with an IC50 value of 19 μM. Proadifen hydrochloride reduces monoamine oxidase A (MAO-A) activity and reverses the antidepressantlike behavioral effect of Imipramine (HY-B1490A) and Desipramine (HY-B1272A) in rats. Proadifen hydrochloride also reduces N, N-dimethyltryptamine (DMT) metabolism in liver microsomes and inhibits N-demethylationand Acridone (HY-W007771) formation. Proadifen hydrochloride augments Lipopolysaccharide (LPS) (HY-D1056)-induced fever and exacerbates Prostaglandin E2 (PGE2) (HY-101952) levels in the rat. Proadifen hydrochloride is promising for research of metabolism-related deseases, ovarian carcinoma, inflammation and dopamine neurons-related deseases [4] .
loading...
    loading...
Cat. No.: HY-W1058437
CAS No.: 131844-46-7
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

(trans)-m-Cl-PCA hydrochloride is a monoamine oxidase inhibitor, with an IC50 of 0.55 μM against rat MAO-A and an IC50 of 0.63 μM against MAO-B. (trans)-m-Cl-PCA hydrochloride inhibits the activities of MAO-A and MAO-B in rat brain mitochondria. (trans)-m-Cl-PCA hydrochloride can be used for the research of neurological disorders .
loading...
    loading...
Cat. No.: HY-124331
CAS No.: 21618-99-5
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

H77-77 is a selective MAO-A inhibitor with blood-brain barrier permeability, exhibiting an IC50 of 7.4 μM against rat MAO-A. H77-77 accumulates via uptake by serotonergic and noradrenergic neurons. H77-77 releases norepinephrine and serotonin from intracellular neuronal storage sites. H77-77 can be used in studies related to neurological disorders .
loading...
    loading...
Cat. No.: HY-124885
CAS No.: 73423-35-5
Target:  

Monoamine Oxidase VAP-1

Research Areas:  

Metabolic Disease

MD 220661 is a semicarbazide-sensitive amine oxidase (SSAO) and monoamine oxidase (MAO) inhibitor, and serves as a major metabolite of MD 240928 in rat brain. MD 220661 acts as a substrate for SSAO and exhibits reversible, selective MAO-B inhibition in rat tissues; in the absence of semicarbazide, its inhibitory potency against MAO-A activity decreases with prolonged pre-incubation time. MD 220661 is applicable to studies related to enzyme-catalyzed metabolism .
loading...
    loading...
Cat. No.: HY-184026
CAS No.: 898540-68-6
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

MAO-B-IN-58 (Compound 2e) is a reversible, selective MAO-B inhibitor with an IC50 of 170 nM against rat MAO-B. MAO-B-IN-58 is applicable for the research of Parkinson's disease and Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-182481
CAS No.: 147807-20-3
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

MD-230254 is a reversible, competitive and selective inhibitor inhibitor of MAO-B with an IC50 value of 1.8 nM. MD-230254 can be used for the study of MAO-B-related neurodegenerative diseases including Parkinson’s disease and Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-184381
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

MAO-B-IN-61 is an orally active, brain-penetrant, highly selective, mixed-type reversible MAO-B inhibitor (IC50 = 14 nM, SI for MAO-A > 2857). MAO-B-IN-61 exhibits no significant cytotoxicity across various human cell lines and demonstrates good metabolic stability in rat and human liver microsomes. In an MPTP (HY-W114750)-induced rat model of Parkinson's disease, MAO-B-IN-61 exhibits significantly improving motor function and positioning itself as a promising candidate for Parkinson's disease research .
loading...
    loading...